Pam - Interview 21  

Pam - Interview 21

Age at Interview: 70
Sex: Female
Background: Pam is a retired solicitor and magistrate. She is married with 2 adult children and 3 step-children. Ethnic background/nationality: White Jewish.

Brief outline:Pam has breast cancer which spread to her bones and liver. She joined an open-label expanded access study of lapatinib and capecitabine, before lapatinib was licensed for general use. She left the study after lapatinib stopped working. (Wife of Tony, Interview 36)

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To read what was said without video or audio, click here
To print the interview’s text, click here
Pam has breast cancer which spread to her bones and liver. Taking a trial drug seemed‘a lifeline’ she could not refuse, despite serious side effects.
 
Pam could only get lapatinib through an open-label expanded access study. She’d have joined a randomised trial if necessary, but feels NICE should approve it now. It’s already available in the US.
 
Pam was told grapefruit, evening primrose oil and antibiotics can interact with the trial drug (lapatinib). She had bad side effects when she took an antibiotic and almost felt like giving up.
 
Pam finds her regular scans reassuring. Talking to fellow patients helps keep her spirits up, and the nurses are very encouraging. Hospital feels like a safe place.
 
Remembering to take the trial tablets is quite daunting. Pam has to save the empty packets and take them back, though that doesn’t prove she actually took the tablets.
 
Pam would like to see more research into the needs and experiences of family carers. Her husband has had to take on a lot while she has been coping with side effects.
 
Pam asks doctors to understand how difficult it is to take in all the information, to be patient when people ask questions, and to spell out all the advantages and disadvantages of the trial.
Clinical trials
   Support our work

Mail to a friend

Send